Cancer Research Institute awards $30.2 million in grants and fellowships to support basic and clinical research in immunology and cancer immunotherapy.
The Phase 2 clinical trial will analyze blood-based biomarkers versus conventional radiography for cancer patients treated with immunotherapy; findings could change direction of lung cancer treatment
The Cancer Research Institute (CRI) was informed on July 16, 2020, that one of our vendors, Blackbaud, experienced a data incident in May of this year.
30 days of immunotherapy education and awareness programming for patients, caregivers, and the others celebrating advances in immuno-oncology research and treatment
Report reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development now than one year ago.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
New research, new treatments, and how we’re working toward a future immune to cervical cancer
Ugur Sahin and Ozlem Tureci, two of this year’s CRI Coley Award recipients, are pioneers of the mRNA vaccines helping us confront COVID-19 and cancer.